Steven T Bird

Summary

Publications

  1. doi request reprint Drospirenone and non-fatal venous thromboembolism: is there a risk difference by dosage of ethinyl-estradiol?
    S T Bird
    Pharmaceutical Outcomes and Policy, College of Pharmacy and Epidemiology, University of Florida, Gainesville, FL 32611, USA
    J Thromb Haemost 11:1059-68. 2013
  2. doi request reprint Polycystic ovary syndrome and combined oral contraceptive use: a comparison of clinical practice in the United States to treatment guidelines
    Steven T Bird
    College of Pharmacy and Epidemiology, Pharmaceutical Outcomes and Policy, University of Florida, Newell Drive HPNP, Gainesville, FL, USA
    Gynecol Endocrinol 29:365-9. 2013
  3. pmc Risk of venous thromboembolism in women with polycystic ovary syndrome: a population-based matched cohort analysis
    Steven T Bird
    Department of Pharmaceutical Outcome and Policy, University of Florida College of Pharmacy, Gainesville, FL, USA
    CMAJ 185:E115-20. 2013
  4. doi request reprint Male breast cancer and 5α-reductase inhibitors finasteride and dutasteride
    Steven T Bird
    U S Department of Health and Human Services U S Food and Drug Administration Center for Drug Evaluation and Research Office of Pharmacovigilance and Epidemiology, Office of Surveillance and Epidemiology Department of Epidemiology, Silver Spring, Maryland Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, Florida
    J Urol 190:1811-4. 2013

Detail Information

Publications4

  1. doi request reprint Drospirenone and non-fatal venous thromboembolism: is there a risk difference by dosage of ethinyl-estradiol?
    S T Bird
    Pharmaceutical Outcomes and Policy, College of Pharmacy and Epidemiology, University of Florida, Gainesville, FL 32611, USA
    J Thromb Haemost 11:1059-68. 2013
    ..Previous studies concluded that there was an increased risk of non-fatal venous thromboembolism (VTE) with drospirenone. It is unknown whether the risk is differential by ethinyl-estradiol dosage...
  2. doi request reprint Polycystic ovary syndrome and combined oral contraceptive use: a comparison of clinical practice in the United States to treatment guidelines
    Steven T Bird
    College of Pharmacy and Epidemiology, Pharmaceutical Outcomes and Policy, University of Florida, Newell Drive HPNP, Gainesville, FL, USA
    Gynecol Endocrinol 29:365-9. 2013
    ..8% versus 15.2%, p < 0.001), indicating some women likely receive metformin solely for PCOS. Our data suggests further attention is needed to medication management of PCOS to bridge the gap between guidelines and practice...
  3. pmc Risk of venous thromboembolism in women with polycystic ovary syndrome: a population-based matched cohort analysis
    Steven T Bird
    Department of Pharmaceutical Outcome and Policy, University of Florida College of Pharmacy, Gainesville, FL, USA
    CMAJ 185:E115-20. 2013
    ..There is an increased risk of venous thromboembolism among women taking oral contraceptives. However, whether there is an additional risk among women with polycystic ovary syndrome (PCOS) is unknown...
  4. doi request reprint Male breast cancer and 5α-reductase inhibitors finasteride and dutasteride
    Steven T Bird
    U S Department of Health and Human Services U S Food and Drug Administration Center for Drug Evaluation and Research Office of Pharmacovigilance and Epidemiology, Office of Surveillance and Epidemiology Department of Epidemiology, Silver Spring, Maryland Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, Florida
    J Urol 190:1811-4. 2013
    ..We examined the association between 5α-reductase inhibitors and male breast cancer...